Clinical trial
Tafenoquine and ACTs (TADORE- Plus)
NCT07060794 is registered in ClinicalTrials.gov with Menzies School of Health Research as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Tafenoquine and ACTs (TADORE- Plus)
- Lead sponsor
- Menzies School of Health Research
- Phase
- Phase 4
- Overall status
- Not yet recruiting
- Start date
- June 30, 2026
- Completion date
- June 30, 2028
- Enrollment
- 507 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
vivax malaria